June 08, 2021
Increasing bone grafting surgeries, development of orthopedic specialty hospitals, and favorable health insurance policies are the major factors augmenting the growth of the global bone grafts and substitutes industry.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3557576/
Further, surging geriatric populace with demand for top quality musculoskeletal functions, in consort with increasing adoption & production of artificial bone grafts, allografts and xenografts as substitutes for real bones are also boosting the growth of the market.
For the unversed, bone grafting is used to medically treat bone associated disorders, by transplanting bone tissue to regenerate and to strengthen bones damaged in accidents.
On the contrary, costly bone graft care, coupled with risks & complications that comes with bone grafting procedures are likely to restrain the bone grafts and substitutes industry outlook over the analysis timeframe.
Speaking of material type, the market is bifurcated into synthetic, allograft, and others. In terms of application gamut, the industry is classified into foot & ankle, craniomaxillofacial, dental, and others.
Considering the geographical landscape, industry dynamics across the United States, the United Kingdom, Japan, Germany, France, Italy, and Spain are scrutinized holistically to calculate the revenue contribution of each nation.
The competitive landscape of worldwide bone grafts and substitutes market is defined by companies such as Baxter International Inc., DePuy Synthes, Arthrex Inc., Zimmer Biomet, Medtronic plc, Integra LifeSciences Holdings Corporation, NuVasive Inc. Stryker Corporation, MTF Biologics (Musculoskeletal Transplant Foundation), and Wright Medical Group N.V. among others.